Nebenwirkungen · Tasigna
Tasigna 50 mg hard capsules Tasigna 150 mg hard capsules Tasigna 200 mg hard capsules · Abschnitt 4.8 · PDF-Seite 15–16
HOS-118236 · Präparat HOS-094783
15 Investigations Very common: Alanine aminotransferase increased, lipase increased Common: Haemoglobin decreased, blood amylase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, blood creatinine phosphokinase increased, weight decreased, weight increased, elevated creatinine, total cholesterol increased Uncommon: Blood lactate dehydrogenase increased, blood urea increased, blood bilirubin unconjugated increased, blood parathyroid hormone increased, blood triglycerides increased, globulins decreased, lipoprotein cholesterol (including low density and high density) increased, troponin increased Rare: Blood glucose decreased, blood insulin decreased, blood insulin increased, insulin C-peptide decreased Note: Not all adverse drug reactions were observed in paediatric studies.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-17T17:21:00Z · SHA-256 efb2ca2c5c7d9a0e740759217e71ff7f08cf3763f8c41f5c02f5d10733d67b3a · Passage 52937288623142e5266049016fbce9a40f6431a03fff2671368f176c194e1f4e · Zeichen 10031–11217 im Abschnitt